Moderna Inc annual net income for fiscal TTM was -$3.2 billion, a decrease of 13.2% from -$2.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($3.2B) | ($2.8B) | ($3.6B) | ($4.7B) | $8.4B | $12.2B | ($747M) | ($514M) | ($385M) | ($256M) | ($216M) | ($1M) | ($6M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | ($1.3B) | ($826M) | ($200M) | ($825M) | ($971M) | ($1.1B) | $13M | ($1.3B) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MRNA metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All MRNA financial statements → Interactive MRNA charts →
About TickerBase · Data methodology & sources